Dihydralazine

DB12945ApprovedWithdrawnSmall molecule

Dihydralazine is under investigation in clinical trial NCT00311974 (The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals).

Chemical structure of Dihydralazine
Formula / weight
C8H10N6 · 190.21 g/mol (avg)
Also known as
Dihydrallazin · Dihydrazinophthalazine
Code names
C 7441

Resolves to

Compound
UNIIPCU411F5L6CAS484-23-1ChEMBLCHEMBL35505ChEBI134841PubChem10230
Clinical / RWD
RxNorm3409ATCC02DB01ATCC02LG01ATCC02LG51
Structure
InChIKeyVQKLRVZQQYVIJW-UHFFFAOYSA-NSMILESNNC1=C2C=CC=CC2=C(NN)N=N1
Targets
P19801AOC1P05164MPO

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
896Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3ATC codesIncluding every combination product, plus 17 drug categories
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dihydralazine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In